Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Thanks for the replies guys, seems a lot of loopholes and overlapping info in trading. Mint have it pretty good whichever way you look at it, if only they’d have actually invested, reassured a lot of us on this bb and then made some real money by selling further down the line with a higher sp.
I still have a hunch Vlads plan regarding globalco would have inverted the initial drop created from the news.
I’m happy to sit on my eggs for as long as it takes.
If no one had sold their shares, would the sp have just stayed the same?
Yes cln means more shares in issue of Hemo, but as the new shares issued immediately were owned by Mint, this in itself shouldn’t have affected sp, in reality just increased mcap.
Am I right in thinking this?
My exact question to myself,
I have held 600k shares for nearly a year. With missed opportunities past and present, this is looking like a pull out for me with a future lower re entry point in say 3 months time, am I on the same wave length as others out there?
I can see Sysmex advertising Genedrive as their only COVID diagnostics? Am I correct in assuming Sysmex gaining the tender directly benefits us??
Also BC, are we their only COVID diagnostics? (Not researched, iPads too slow)
https://www.med-technews.com/news/salford-university-supplies-ppe-and-testing-equipment-to-com/
Sadly I think it’s Salford Uni who have the test kit??
RNSs will land, My thread was started aimed at the premature ejaculators of the group. It’s exasperating reading the same spiel. Guys just chill, a quality BB is far better than a quantity Of the same guessy guessy hype.